GREEN VISION BIOTECHNOLOGY CORP.
Rooms 1804-06, 18/F, Wing On House, 71 Des Voeux Road Central, Hong Kong |
Date: May 5, 2022
US Securities and Exchange Commission
100 F Street, N.E.
Washington D.C. 20549
U.S.A.
Dear Sirs or Madams,
Re: GVBT Form 10-K for the year ended December 31, 2021
Green Vision Biotechnology Corp. (“GVBT”) received a comment letter from the Securities and Exchange Commission (the “SEC”) related to the filing mentioned above. The SEC requested that GVBT respond to the comments through filing of a 10-K/A by May 16, 2022. GVBT requested an extension to May 30, 2022. The SEC granted such extension. GVBT plans to file the subject 10-K/A on or before May 30, 2022.
Should you have any further queries, please do not hesitate to contact the undersigned at +852-2913 9930/+852-9492-9967, or our legal representative in the USA, Mr. Matthew McMurdo, McMurdo Law Group, LLC, at 917-318-2865.
Thank you for your kind attention.
Yours sincerely,
For and on behalf of GREEN VISION BIOTECHNOLOGY CORP.
/s/ Lam Ching Wan, William | |
Lam Ching Wan, William | |
Chief Executive Officer | |
Encls |